According to WHO more than 470 million or 39% of Indians suffer from gastrointestinal problems varying from heartburn to constipation and diarrhea.
The purpose of Fourrts gastro division is to bridge the therapy gaps in the management of Gastro-intestinal disorders by offering innovative brands that offer end-to-end solutions.
Gastrointestinal (GI) disorders are increasingly prevalent in India, significantly impacting individuals’ quality of life. A study in rural Uttar Pradesh found that approximately 22% of adults suffer from functional GI disorders (FGIDs) such as dyspepsia and irritable bowel syndrome (IBS), with risk factors including tobacco use, consumption of aerated drinks, disturbed sleep, and anxiety. These conditions not only cause physical discomfort but also contribute to psychological distress, highlighting the intricate connection between gut health and mental well-being. Healthcare interventions play a crucial role in managing these disorders. Therapeutic approaches, including dietary modifications, pharmacological treatments, and psychological support, have effectively alleviated symptoms and improved patients’ quality of life.
Recent studies reveal that approximately 22% of Indian adults suffer from constipation, while 7.6% to 30% experience gastroesophageal reflux disease (GERD), underscoring the widespread prevalence of gastrointestinal issues across the country. These disorders not only cause physical discomfort but also significantly affect mental well-being, highlighting the urgent need for comprehensive healthcare solutions. Fourrts’ Gastro Division is dedicated to addressing therapy gaps in the management of gastrointestinal disorders by providing innovative brands with proven efficacy. Through advanced research, patient-centric care, and an unwavering commitment to excellence, Fourrts strives to enhance digestive health and improve the overall quality of life for individuals.